Annual Accounts Payable
$9.94 M
+$7.07 M+246.91%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual accounts payable is $9.94 million, with the most recent change of +$7.07 million (+246.91%) on December 31, 2023.
- During the last 3 years, PBLA annual accounts payable has risen by +$9.38 million (+1694.04%).
- PBLA annual accounts payable is now at all-time high.
Performance
PBLA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$10.95 M
-$3.34 M-23.39%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly accounts payable is $10.95 million, with the most recent change of -$3.34 million (-23.39%) on September 30, 2024.
- Over the past year, PBLA quarterly accounts payable has increased by +$1.01 million (+10.17%).
- PBLA quarterly accounts payable is now -23.39% below its all-time high of $14.29 million, reached on June 30, 2024.
Performance
PBLA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PBLA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +246.9% | +10.2% |
| 3 y3 years | +1694.0% | +49.2% |
| 5 y5 years | +834.1% | +49.2% |
PBLA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1453.0% | -23.4% | +1610.9% |
| 5 y | 5-year | at high | +1694.0% | -23.4% | +3940.6% |
| alltime | all time | at high | >+9999.0% | -23.4% | >+9999.0% |
Panbela Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.95 M(-23.4%) |
| Jun 2024 | - | $14.29 M(+68.0%) |
| Mar 2024 | - | $8.51 M(-14.4%) |
| Dec 2023 | $9.94 M(+246.9%) | $9.94 M(+50.3%) |
| Sep 2023 | - | $6.61 M(-21.7%) |
| Jun 2023 | - | $8.44 M(+15.0%) |
| Mar 2023 | - | $7.34 M(+156.2%) |
| Dec 2022 | $2.87 M(+347.7%) | $2.87 M(-46.9%) |
| Sep 2022 | - | $5.39 M(+68.0%) |
| Jun 2022 | - | $3.21 M(-19.4%) |
| Mar 2022 | - | $3.99 M(+522.8%) |
| Dec 2021 | $640.00 K(+15.5%) | $640.00 K(-19.6%) |
| Sep 2021 | - | $796.00 K(+1.9%) |
| Jun 2021 | - | $781.00 K(-0.1%) |
| Mar 2021 | - | $782.00 K(+41.2%) |
| Dec 2020 | $554.00 K(-7.2%) | $554.00 K(+31.3%) |
| Sep 2020 | - | $422.00 K(-14.4%) |
| Jun 2020 | - | $493.00 K(+81.9%) |
| Mar 2020 | - | $271.00 K(-54.6%) |
| Dec 2019 | $597.00 K(-43.9%) | $597.00 K(+128.7%) |
| Sep 2019 | - | $261.00 K(-9.7%) |
| Jun 2019 | - | $289.00 K(-68.1%) |
| Mar 2019 | - | $905.00 K(-14.9%) |
| Dec 2018 | $1.06 M | $1.06 M(+4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $1.02 M(+8.7%) |
| Jun 2018 | - | $936.00 K(-23.4%) |
| Mar 2018 | - | $1.22 M(+2.2%) |
| Dec 2017 | $1.20 M(-3.9%) | $1.20 M(+36.8%) |
| Sep 2017 | - | $874.00 K(+35.9%) |
| Jun 2017 | - | $643.00 K(-39.5%) |
| Mar 2017 | - | $1.06 M(-14.7%) |
| Dec 2016 | $1.25 M(+112.8%) | $1.25 M(+16.5%) |
| Sep 2016 | - | $1.07 M(+34.1%) |
| Jun 2016 | - | $797.00 K(-1.4%) |
| Mar 2016 | - | $808.00 K(+38.1%) |
| Dec 2015 | $585.00 K(+97.0%) | $585.00 K(-8.3%) |
| Sep 2015 | - | $638.00 K(>+9900.0%) |
| Jun 2015 | - | $1400.00(-86.5%) |
| Mar 2015 | - | $10.40 K(-96.5%) |
| Dec 2014 | $297.00 K(+7325.0%) | $297.00 K(+8635.3%) |
| Sep 2014 | - | $3400.00(-73.0%) |
| Jun 2014 | - | $12.60 K(-0.8%) |
| Mar 2014 | - | $12.70 K(+217.5%) |
| Dec 2013 | $4000.00(-85.8%) | $4000.00(-71.4%) |
| Sep 2013 | - | $14.00 K(-5.4%) |
| Jun 2013 | - | $14.80 K(-63.7%) |
| Mar 2013 | - | $40.80 K(+45.2%) |
| Dec 2012 | $28.10 K(-27.4%) | $28.10 K |
| Dec 2011 | $38.70 K | - |
FAQ
- What is Panbela Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Panbela Therapeutics?
- What is Panbela Therapeutics annual accounts payable year-on-year change?
- What is Panbela Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly accounts payable year-on-year change?
What is Panbela Therapeutics annual accounts payable?
The current annual accounts payable of PBLA is $9.94 M
What is the all time high annual accounts payable for Panbela Therapeutics?
Panbela Therapeutics all-time high annual accounts payable is $9.94 M
What is Panbela Therapeutics annual accounts payable year-on-year change?
Over the past year, PBLA annual accounts payable has changed by +$7.07 M (+246.91%)
What is Panbela Therapeutics quarterly accounts payable?
The current quarterly accounts payable of PBLA is $10.95 M
What is the all time high quarterly accounts payable for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly accounts payable is $14.29 M
What is Panbela Therapeutics quarterly accounts payable year-on-year change?
Over the past year, PBLA quarterly accounts payable has changed by +$1.01 M (+10.17%)